You are here: Industry Insights > potassium

News List

Sandoz Recalls Losartan Potassium, Ezetimibe Prescription Bottles americanpharmaceuticalreview
September 03, 2019
Sandoz has voluntarily recalled losartan potassium and ezetimibe in prescription drug bottles in the U.S. due to failure to meet child-resistant closure requirements.
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc. drugs
June 12, 2019
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc.
Ruzurgi Approved for Pediatric Lambert-Eaton Myasthenic Syndrome (LEMS) drugs
June 03, 2019
Ruzurgi Approved for Pediatric Lambert-Eaton Myasthenic Syndrome (LEMS).
Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Impurity drugs
May 20, 2019
Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Impurity.
Sandoz Issues Recall of Losartan Potassium, Hydrochlorothiazide americanpharmaceuticalreview
November 12, 2018
Sandoz Issues Recall of Losartan Potassium, Hydrochlorothiazide
EU approves AZ’ potassium binder for hyperkalaemia pharmatimes
July 20, 2018
AstraZeneca’s Lokelma has been approved in Europe to treat hyperkalaemia in adult patients.